Xiao Ke Zhi Ping Capsule For Obese Type2Diabetes Mellitus And Dysiipidemia(Qi Yin Liang Xu Jia Tan Yu Zheng) Clinical Observation

Purpose: To use of Chinese medicine which named xiao ke zhi ping jiao nang treatment offat T2DM and dyslipidemia.For clinical medical record through observation and comparison ofclinical effectiveness before and after medication and relative advantages of western medicinetreatment.Methods: According to the Chinese herbal medicine new medicine clinical research guidingprinciple requirement, the prospective randomized, the design of outpatient service and thetreatment in patients with diagnosis standard were studied in the60patients with type2diabeteswho are obese patients with dyslipidemia, random distinguish between the control group and thetreatment group for the30cases. Two groups based in diabetes treatment, and on the basis of thecontrol group simply give western medicine glucophage oral, the treatment group is in the controlgroup treatment on the basis of add with xiao ke zhi ping jiao nang.Treatment observation12weeks, compared to the clinical symptoms before and after treatment and analyzed.Results: For the treatment of before and after the treatment group was better than controlsymptoms improve.Treatment group total effectiveness90%, the control group totaleffectiveness76.67%. Two group total effectiveness was significant difference (P <0.05).Conclusion: The curative effect of treatment group and control group compared withsignificant differences markedly effective treatment group in9(30%), effective18cases (60%),3case ineffective (10%), the total effective rate of90%. The control group30cases,5cases(16.67%), effective18cases (60%), invalid in7patients (23.33%), the total effective rate was76.67%. Observation results show that nearly flat compared to the control group fat capsule inimproved clinical symptoms were good advantage, safe and non-toxic side effects. For traditionalChinese medicine for obese type2diabetes mellitus and dyslipidemia the application to providethe scientific basis, thereby improving the traditional Chinese medicine to obese type2diabetesprevention and cure of merger dyslipidemia research level.